» Articles » PMID: 167434

Adenosine Inhibition of Lymphocyte-mediated Cytolysis: Possible Role of Cyclic Adenosine Monophosphate

Overview
Journal Science
Specialty Science
Date 1975 Mar 14
PMID 167434
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The in vitro destruction of tumor cells by specifically sensitized mouse lymphocytes was inhibited by adenosine; this inhibition was markedly potentiated by the presence of an inhibitor of adenosine deaminase. The inhibition of cytolysis by adenosine was accompanied by a rapid elevation in lymphocytic adenosine 3',5'-monophosphate (cyclic AMP) concentrations. Both the inhibition of cytolysis and the elevation of cyclic AMP were reversed by prolonged incubation of the lymphocytes in the presence of adenosine or, more rapidly, by removal of the adenosine. Low concentrations of adenosine also caused an elevation of cyclic AMP in human lymphocytes, and this effect of adenosine may contribute to the lack of immune response associated with adenosine deaminase deficiency.

Citing Articles

Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023.

Zhang S, Miao L, Tian X, Yang B, Luo B Hum Vaccin Immunother. 2025; 21(1):2440203.

PMID: 39885669 PMC: 11792843. DOI: 10.1080/21645515.2024.2440203.


The Adenosinergic Pathway in Non-Small Cell Lung Cancer.

Van Kerkhove O, Verfaillie S, Maes B, Cuppens K Cancers (Basel). 2024; 16(18).

PMID: 39335114 PMC: 11430550. DOI: 10.3390/cancers16183142.


Immune interactions and regulation with CD39 extracellular vesicles from platelet concentrates.

Delorme A, Laguide A, Tamagne M, Pinheiro M, Cagnet L, Neyrinck-Leglantier D Front Immunol. 2024; 15:1397967.

PMID: 38947317 PMC: 11211594. DOI: 10.3389/fimmu.2024.1397967.


Friend or Foe - Tc17 cell generation and current evidence for their importance in human disease.

Hipp A, Bengsch B, Globig A Discov Immunol. 2024; 2(1):kyad010.

PMID: 38567057 PMC: 10917240. DOI: 10.1093/discim/kyad010.


Cell metabolism-based optimization strategy of CAR-T cell function in cancer therapy.

Li W, Pan X, Chen L, Cui H, Mo S, Pan Y Front Immunol. 2023; 14:1186383.

PMID: 37342333 PMC: 10278966. DOI: 10.3389/fimmu.2023.1186383.